A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model

Otolaryngology - Head and Neck Surgery (United States)

Volumn 151, Issue 3, 2014, Pages 447-453

  Lin, Yuan ^a,b   Luo, Jie ^a,b   Zhu, Weichao Eric ^c   Srivastava, Minu ^a,d   Schaue, Dorthe ^b   Elashoff, David A ^a,b   Dubinett, Steven M ^a,b,d   Sharma, Sherven ^a,d   Wu, Benjamin ^a,b,c   St John, Maie A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

head and neck cancer; novel therapeutics; polymer; squamous cell carcinoma

Indexed keywords

CISPLATIN; EPSILON CAPROLACTONE LACTIDE COPOLYMER; POLYCAPROLACTONE; POLYMER; RECOMBINANT CCL21; RECOMBINANT CYTOKINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; MOUSE; NONHUMAN; TUMOR VOLUME;

HEAD AND NECK CANCER; NOVEL THERAPEUTICS; POLYMER; SQUAMOUS CELL CARCINOMA;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C3H; POLYMERS; RANDOM ALLOCATION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84908278701     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814533775     Document Type: Article

References (35)

1. Ferlay J, Bray F, Pisani P, et al GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Geneva, Switzerland: World Health Organization ; 2001 :
2. Shikani AH, Domb AJ. Polymer chemotherapy for head and neck cancer. Laryngoscope. 2000 ; 110: 907-917 (Pubitemid 30368630)
3. Ross DA, Hundal JS, Son YH, et al. Microsurgical free flap reconstruction outcomes in head and neck cancer patients after surgical extirpation and intraoperative brachytherapy. Laryngoscope. 2004 ; 114: 1170-1176 (Pubitemid 38954568)
4. Xian J, Yang H, Lin Y, et al. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2005 ; 131: 1079-1085 (Pubitemid 41815882)
5. Polymeric Site-Specific Pharmacotherapy. Domb AJ, ed. New York, NY: John Wiley ; 1994 :
6. Handbook for Biodegradable Polymers. Domb AJ Kost J Wiseman D, ed. Amsterdam, Netherlands: Harwood Academic Publishers ; 1997 :
7. Cohen EM, Ding H, Kessinger CW, Khemtong C, Gao J, Sumer BD. Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells. Otolaryngol Head Neck Surg. 2010 ; 143: 109-115
8. Hu D, Lau OD, Wang L, et al. A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model. Arch Otolaryngol Head Neck Surg. 2012 ; 138: 412-417
9. Mandpe AH, Tsung K, Norton JA. Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice. Arch Otolaryngol Head Neck Surg. 2003 ; 129: 786-792 (Pubitemid 36858969)
10. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem. 1998 ; 273: 7118-7122 (Pubitemid 28160383)
11. Scheller EL, Krebsbach PH. Gene therapy: design and prospects for craniofacial regeneration. J Dent Res. 2009 ; 88: 585-596
12. Kuriakose MA, Chen FA, Egilmez NK, et al. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model. Head Neck. 2000 ; 22: 57-63 (Pubitemid 30030670)
13. Wang L Sequential Layer Polymer Deposition. Los Angeles, CA: UCLA Biomedical Engineering ; 2010 :
14. O'Malley BW, Cope KA, Johnson CS, et al. A new immunocompetent murine model for oral cancer. Arch Otol. 1997 ; 123: 20-24 (Pubitemid 27043653)
15. Stuschke M, Pottgen C. Altered fractionation schemes in radiotherapy. Front Radiat Ther Oncol. 2010 ; 42: 150-156
16. Deurloo MJ, Kop W, van Tellingen O, Bartelink H, Begg AC. Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution. Cancer Chemother Pharmacol. 1991 ; 27: 347-353
17. Ning S, Yu N, Brown DM, Kanekal S, Knox SJ. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system. Radiother Oncol. 1999 ; 2: 215-223 (Pubitemid 29155548)
18. Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials. 1996 ; 17: 103
19. Yu NY, Conley FK, Luck EE, et al. Response of murine tumors to matrix-associated cisplatin intratumoral implants. NCI Monogr. 1988 ; 6: 137-140 (Pubitemid 18047978)
20. Vikram B, Mishra S. Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck. 1994 ; 16: 155-157 (Pubitemid 24080610)
21. Jewett A, Cacalano NA, Teruel A, et al. Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation. Cancer Immunol Immunother. 2006 ; 55: 1052-1063 (Pubitemid 43800720)
22. Wang J, Xi L, Hunt JL, et al. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res. 2004 ; 64: 1861-1866 (Pubitemid 38428712)
23. Wang J, Seethala RR, Zhang Q, et al. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. J Natl Cancer Inst. 2008 ; 100: 502-512
24. Haessler U, Pisano M, Wu M, Swartz MA. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc Natl Acad Sci U S A. 2011 ; 108: 5614-5619
25. Christopherson KW, Campbell JJ, Hromas RA. Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration. Blood. 2001 ; 98: 3562-3568
26. Somanchi SS, Somanchi A, Cooper LJ, Lee DA. Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7. Blood. 2012 ; 119: 5164-5172
27. Marcenaro E, Cantoni C, Pesce S, et al. Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood. 2009 ; 114: 4108-4116
28. Le Maux Chansac B, Moretta A, Vergnon I, et al. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol. 2005 ; 175: 5790-5798 (Pubitemid 41508063)
29. Li W, Sofi MH, Wei DG, et al. MHC class II-expressing thymocytes suppress invariant NKT cell development. Immunol Cell Biol. 2009 ; 87: 186-189
30. Sharma S, Yang SC, Hillinger S, et al. SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10. Mol Cancer. 2003 ; 2: 22
31. Sharma S, Stolina M, Luo J, et al. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol. 2000 ; 164: 4558-4563 (Pubitemid 30238052)
32. Sharma S, Stolina M, Zhu L, et al. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 2001 ; 61: 6406-6412 (Pubitemid 32783246)
33. Yang SC, Batra RK, Hillinger S, et al. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res. 2006 ; 66: 3205-3213
34. Vicari AP, Ait-Yahia S, Chemin K, Mueller A, Zlotnik A, Caux C. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J Immunol. 2000 ; 165: 1992-2000 (Pubitemid 30643148)
35. Arenberg DA, Zlotnick A, Strom SR, Burdick MD, Strieter RM. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model. Cancer Immunol Immunother. 2001 ; 49: 587-592 (Pubitemid 33783074)